27
Views
18
CrossRef citations to date
0
Altmetric
Original Article

The Use of a Silymarin/Phospholipid Compound as a Fetoprotectant from Ethanol-Induced Behavioral Deficits

, , &
Pages 39-47 | Received 25 Jan 2001, Accepted 19 Apr 2001, Published online: 20 Aug 2009
 

Abstract

We have replicated an earlier study in which silymarin/ phytosome appeared to prevent deficits in social memory function in male rats exposed in utero to ethanol (EtOH).1 Female rats were included in the current study as well as a second behavioral test, the radial arm maze. Pregnant Sprague-Dawley rats were provided with liquid diets containing 35% ethanol derived calories (EDC). The silybin/phospholipid compound (SI) was co-administered with EtOH to the experimental group. The offspring were tested at age 90 days on the social recognition task and at 75 days on the radial arm maze. Female EtOH-exposed offspring performed more poorly on the radial arm maze than did female EtOH/SI offspring and the offspring of female controls. Male EtOH-exposed offspring were less able to form social memories than the male EtOH/SI offspring and the offspring of male controls.

Additional information

Notes on contributors

Jolene King

F. U. Alakbarov is Head Scientific Officer, expert in the Oriental and Folk Medicine, Institute of Manuscripts of the Azerbaijan Academy of Sciences, 8 Istiglaliyat str., Baku, 370001, Azerbaijan.

At the time of writing Liya Davydov was PharmD candidate, College of Pharmacy and Allied Health Professions, St. John's University. Currently, she is Pharmacy Practice Resident, Mount Sinai Medical Center, New York, NY.

Ila Mehra Harris is Assistant Professor, Department of Pharmaceutical Care & Health Systems, College of Pharmacy, and Clinical Assistant Professor, Department of Family Practice & Community Health, Medical School, University of Minnesota, Minneapolis, MN.

Colin J. Briggs is Professor of Pharmacy, Faculty of Pharmacy, University of Manitoba. Recently he completed a secondment to Health Canada, as Senior Science Advisor in the Therapeutics Products Programme with special responsibility for complementary medicines.

Gemma Briggs is Research Assistant, IMPACT, The Injury Prevention Centre of Children's Hospital, 501G-715 John Buhler Research Centre, Winnipeg, MB, Canada.

Mary Chavezis Professor of Pharmacy Practice, Director of Complementary Medicine Education and Research, The Center for the Advancement of Pharmacy Practice, Midwestern University, College of Pharmacy Glendale, Glendale, AZ 85308.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.